As a result of the tender offer, Danaher owned, together with its subsidiaries, approximately 91.6% of the outstanding shares of IRIS, which allowed Danaher to complete and close the merger and acquisition of IRIS on October 31, 2012, without stockholder approval. Upon completion of the merger, IRIS became a wholly-owned subsidiary of Danaher. All outstanding shares of common stock of IRIS, other than shares held by Danaher, Daphne Acquisition Corporation or IRIS in treasury or shares held by IRIS's stockholders who are entitled to and properly exercise appraisal rights under Delaware law, were canceled and converted into the right to receive cash equal to the $19.50 offer price per share without interest thereon and less any applicable withholding taxes. In addition, in connection with the merger, the common stock of IRIS will cease to be traded on the NASDAQ Stock Market.
About Danaher
Danaher is a science and technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our premier brands are among the most highly recognized in each of the markets we serve. The Danaher Business System provides a foundation to our 59,000 associates around the world, serving customers in more than 125 countries. In 2011, we generated $16.1 billion of revenue. For more information please visit our website: www.danaher.com.
Danaher contact:
Matt R. McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, NW
Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Danaher Corporation via Thomson Reuters ONE
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.